ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ONC Oncimmune Holdings Plc

24.30
-0.50 (-2.02%)
14 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Oncimmune Holdings Plc LSE:ONC London Ordinary Share GB00BYQ94H38 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50 -2.02% 24.30 23.60 25.00 15,929 16:35:10
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Medical Laboratories 1.47M -6.15M -0.0830 -2.99 18.39M

Oncimmune Holdings PLC Block Listing Six Monthly Return (5398U)

06/04/2021 1:48pm

UK Regulatory


Oncimmune (LSE:ONC)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Oncimmune Charts.

TIDMONC

RNS Number : 5398U

Oncimmune Holdings PLC

06 April 2021

6 April 2021

Oncimmune Holdings plc

("Oncimmune" or the "Company")

Block Listing Six Monthly Return

Oncimmune makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements in respect of Oncimmune Holdings Plc 2016 Unapproved and EMI Share Option Plans (the "Share Option Plans").

 
 Name of applicant:                            Oncimmune Holdings plc 
 Name of scheme:                               Oncimmune Holdings Plc 2016 
                                                Unapproved and EMI Share Option 
                                                Plans 
                                              --------------------------------- 
 Period of return:                             15 September 2020 to 15 March 
                                                2021 
                                              --------------------------------- 
 Balance of unallotted securities 
  under scheme(s) from previous 
  return:                                       5,998,772 
                                              --------------------------------- 
 Plus: The amount by which the 
  block scheme(s) has been increased 
  since the date of the last return 
  (if any increase has been applied 
  for):                                        0 
                                              --------------------------------- 
 Less: Number of securities issued/allotted 
  under scheme(s) during period:                168,618 
                                              --------------------------------- 
 Equals: Balance under scheme(s) 
  not yet issued/allotted at end 
  of period:                                    5,830,154 
                                              --------------------------------- 
 

For further information:

Oncimmune Holdings plc

Ron Kirschner, Company Secretary

contact@oncimmune.co.uk

Zeus Capital Limited (Nominated Adviser and Joint Broker)

Andrew Jones, Daniel Harris, Victoria Ayton

+44 (0)20 3829 5000

N+1 Singer (Joint Broker)

Aubrey Powell, Harry Gooden, Iqra Amin, James Fischer

+44 (0)20 7496 3000

WG Partners (Joint Broker)

David Wilson, Chris Lee

+44 (0)203 705 9321

Media enquiries:

FTI Consulting

Ben Atwell, Michael Trace, Alex Davis

Oncimmune@fticonsulting.com

+44 (0)20 3727 1000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BLRSSWFEMEFSELL

(END) Dow Jones Newswires

April 06, 2021 08:48 ET (12:48 GMT)

1 Year Oncimmune Chart

1 Year Oncimmune Chart

1 Month Oncimmune Chart

1 Month Oncimmune Chart

Your Recent History

Delayed Upgrade Clock